Despite the prevalence of concussion in soldiers deployed to Iraq and Afghanistan, neuropsychological tests used to assist in concussion management have not been validated on the battlefield. This study evaluated the validity of the Automated Neuropsychological Assessment Metrics (ANAM) in the combat environment. Cases meeting criteria for concussion, healthy controls, and injured controls were assessed. Soldiers were administered the ANAM, traditional neuropsychological tests, and a background questionnaire. Cases were enrolled within 72 h of concussion. Cases exhibited poorer performance than controls on all ANAM subtests, with significant differences on simple reaction time (SRT), procedural reaction time (PRT), code substitution, and matching to sample (p , .001). Discriminant ability of scores on SRT and PRT subtests was 71%, which improved to 76% when pre-deployment baseline scores were available. An exploratory clinical decision tool incorporating ANAM scores and symptoms improved discriminant ability to 81%. Results provide initial validation of the ANAM for detecting acute effects of battlefield concussion.
discrepancy with a Type I error rate of 0.05 using a two-tailed t-test and assuming a mean T-score of 50 and a standard deviation of 10 for control subjects. This sample size has been used in similar published studies (e.g., Bleiberg, Kane, Reeves, Garmoe & Halpern, 2000; Kabat, Kane, Jefferson, & DiPino, 2001) .
This study was approved by the institutional review board of Brooke Army Medical Center. All participants provided written informed consent before enrollment.
Participants
Cases included all U.S. Army soldiers meeting eligibility criteria presenting to an outpatient medical facility within 72 h of a concussion. The 72-h window was chosen as it has successfully been used previously in validation of neuropsychological measures in sports concussion (e.g., Broglio et al., 2007a; Pellman, Lovell, Viano, & Casson, 2006) and outpatient civilian (Hugenholtz, Stuss, Stetham, & Richard, 1988) settings and was estimated to be a reasonable time frame in which to enroll participants in view of combat operations considerations. Eligible participants had to be 18 -50 years old, meet Department of Defense criteria for concussion (Department of Defense, 2007) , be free of cognition altering medication, have no severe psychiatric diagnosis requiring ongoing therapy (i.e., ongoing medication management by a psychiatrist), report pain not more than 7 of 10, and give consent. Individuals with prior severe TBI, moderate TBI within the previous 3 years, or any concussion within the previous 90 days were excluded. Although multiple concussion grading systems exist, none is currently utilized by the Department of Defense to manage concussion in the deployed setting (Barth et al., 2010) and hence no grading system was employed in this project. To minimize fatigue effects participants had to have a night's rest before testing. Two control groups were enrolled. The first control group was a healthy group of U.S. Army soldiers from deployed units volunteering for participation. The second group consisted of acutely injured (within 72 h) U.S. Army soldiers presenting for outpatient care who were neither head-injured nor exposed to a blast. This group was recruited to control for negative neurocognitive effects of non-concussive injury. In addition to the inclusion/exclusion criteria for cases, controls could not have suffered a concussion during this deployment.
Questionnaire and Neuropsychological Testing
Participants were administered a questionnaire with items assessing demographics (including self-identified race, per Common Data Elements recommendations [Maas, Harrison-Felix, & Menon, 2010] ), physical health, mental health, sleep, and other service-related factors. Physical and mental health were rated on a 1 ("poor") to 5 ("excellent") scale and pain on a 0 ("none") to 10 ("severe") scale. Cases were asked about the presence and duration of loss of consciousness (LOC) or posttraumatic amnesia (PTA) and time since injury. The study team had originally planned to obtain information from cases and/or collateral sources allowing distinction between LOC and PTA, but the circumstances under which many injuries occurred (e.g., blast injuries) often made this distinction impossible. Therefore, for purposes of analysis, cases reporting a period of time for which they had no memory post-injury (and may possibly have been unconscious) were combined with those with known or suspected LOC.
The neuropsychological tests administered include the Military Acute Concussion Evaluation (MACE), the ANAM-IV-TBI, and a battery of traditional neuropsychological tests used previously in the study of sports-related concussion including the Hopkins Verbal Learning Test-Revised, Symbol Digit Modalities Test, Stroop Test, Trail Making Test, and Controlled Oral Word Association Test (Barr et al., 2008) . The Test of Memory Malingering (TOMM) was administered to control for poor effort. ANAM-IV-TBI results are reported as T-scores.
The ANAM-IV-TBI (hereafter referred to as the ANAM) includes six subtests: Simple reaction time (SRT), procedural reaction time (PRT), code substitution (CDS), CDS delayed (CDD), mathematical processing (MTH), and matching to sample (MSP). The ANAM subtests have been fully described in a previous article in this journal (Reeves, Winter, Bleiberg, & Kane, 2007) . Briefly, the SRT provides a measure of simple reaction time. PRT is a choice reaction time measure that requires the participant to choose between sets of numbers and is included to assess the processing speed. CDS is a symbol-digit pairing task included to tap learning, whereas CDD evaluates delayed memory for the CDS associations. MTH involves performing single-digit multistep arithmetic operations and is designed to evaluate the working memory capacity. MSP assesses recognition memory for a 4 × 4 colored matrix and is included as a measure of spatial memory. The ANAM and similar reaction timebased measures have been shown in multiple studies to be sensitive to the effects of concussion in the early post-injury period and to provide an objective indicator of recovery of brain function in days to weeks post-injury (e.g., Bleiberg et al., 2004; Broglio et al., 2007a; Schatz et al., 2006; Van Kampen et al., 2006; Warden et al., 2001) . Throughput scores, reflecting composite speed and accuracy, were analyzed. When available, pre-deployment baseline results were retrieved from the Army Neurocognitive Assessment Branch.
Data Analysis
Statistical analysis was performed using Stata v11.1 (Stata Corp., College Station, TX, USA). As the data were not normally distributed, proportions were compared using Fisher's exact test, and continuous data with the Mann -Whitney U-test, the Wilcoxon signed-rank test, or/and the Kruskal-Wallis test. A p-value of ,.05 is considered statistically significant. To address the issue of possible Type I error, the Bonferroni corrections were calculated for all sets of comparisons.
Covariates are initially reported in accordance with Common Data Elements recommendations (Maas et al., 2010) . However, for statistical analysis, many of these were collapsed.
To compare the tests' ability to discriminate cases versus controls, we examined the area under the receiver operating characteristic (ROC) curve and the discriminant ability, defined as the average of the sensitivity and specificity (Riegelman, 2004) .
Results

Demographics
Initially, 71 cases and 166 controls were enrolled. Two cases were excluded after demonstrating poor effort on the TOMM (the first case obtained a score of 29 of 50 on Trial 1 and 18 of 50 on Trial 2; the second case obtained a score of 37 of 50 on Trial 1 and testing was aborted after he began behaving too inappropriately to continue). Only three cases were women. Because there are indications that gender differences may exist in outcomes from concussions (Dick, 2009 ) and the number of female cases was too small to permit the assessment of potential gender effects, analysis was limited to men, excluding 3 female cases and 20 female controls. The final group consists of 212 participants: 66 cases and 146 controls (86 healthy and 60 injured).
Healthy and injured controls were combined for analysis, although these were somewhat different groups. The unit controls were younger than the injured controls (median age 24 vs. 27, p ¼ .0011), more often enlisted (74% vs. 52%, p ¼ .011), had fewer years of service (median 3 vs. 5.25, p ¼ .0064), and fewer had more than two combat tours (2% vs. 20%, p ¼ .002). There was no statistical difference in other factors examined. None of these covariates correlated significantly with altered test performance in later analysis. Later analysis revealed no statistically significant difference between these groups' neuropsychological testing performance. Therefore, combining these groups is considered valid and acceptable to improve power.
Study group demographics, symptoms, and blast/concussion exposure history are presented in Table 1 . Continuous data are reported as medians and interquartile ranges, dichotomous data as number and percentage answering yes, and categorical data as number and percent in each category.
The median age of cases and controls was 25. Cases had a larger proportion of participants with less than high school education, though with the Bonferroni correction applied this difference was no longer significant. There was no significant difference in marital status, race, or English as a second language. One of the cases reported having a moderate TBI previously, but the injury occurred .3 years prior to the study and he was therefore included in the sample, per the previously described inclusion criteria.
Physical Health, Mental Health, Sleep Patterns, and Other Service-Related Variables Cases reported more headaches, blackouts, confusion, and flashbacks. Cases also endorsed more frequent alcohol problems. Both groups reported a median of 6 h of nightly sleep. There was a statistically significant difference in sleep change, with cases reporting more sleep loss.
Cases had been in Iraq fewer months and more often reported previous improvised explosive device exposures.
Neuropsychological Testing Scores
Results of the MACE have been reported previously (Coldren, Kelly, Parish, Dretsch, & Russell, 2010) and detailed results of the traditional neuropsychological testing are beyond the scope of this manuscript. Table 2 presents the ANAM results, comparing cases and controls. We examined differences in group medians between cases and controls (see "Baseline group median" and "Enrollment group median" columns of Table 2 ) as well as differences in median individual change (see "Individual change median" column of Table 2 ). Although the examination of median individual change is more clinically meaningful than group change, as this inherently corrects for biases and for individual baseline variation, the number of baseline scores available for analysis was relatively low, reducing power. Therefore, to increase the power of our analysis, we analyzed differences in group medians at enrollment ("Enrollment group median" column of Table 2 ). We included the analysis of group medians at baseline (see "Baseline group median" of Table 2 ) to ensure that any differences in group medians detected at enrollment were not due to differences at baseline. An additional advantage of analyzing scores at enrollment is that this may be the only data point available to the military clinician at the time of initial evaluation in theater. Pre-deployment baseline ANAM results were available for 34 cases and 45 controls ("Baseline group median" column of Table 2 ). There was no difference between cases and controls at the pre-deployment baseline for any ANAM subtest.
At the time of enrollment, cases performed more poorly than controls on all ANAM subtests, with the differences reaching statistical significance on SRT, PRT, CDS, and MSP ("Enrollment group median" column of Table 2 ). Examining median individual changes from the pre-deployment baseline to enrollment demonstrated that for cases, SRT (p ¼ .001), PRT (p ¼ .0106), and MSP (p ¼ .0183) performance declined significantly. MTH also declined but the change did not reach statistical significance. CDS improved for cases while CDD declined, but neither reached significance. Controls improved on all subtests with SRT (p ¼ .0207), MTH (p ¼ .0030), and MSP (p ¼ .013) reaching significance. As described in Table 2 ("Individual change median" column), there were significant differences in ANAM subtest score changes between cases and controls for all subtests except CDD and PRT ("Individual change median" column of Table 2 ). ROC, Discriminant Ability, Sensitivity, and Specificity Table 3 reports the area under the ROC curve, discriminant ability, and the sensitivity and specificity of the tests at the score maximizing discriminant ability. At enrollment, SRT performed best with an area under the ROC curve of 0.71 and discriminant ability of 69%. Adding SRT and PRT scores (SRT + PRT) yields an improved area under the ROC curve of 0.73 and discriminant ability of 71%. No other single test or test combination improves these scores.
If baselines are available, the area under the ROC curve, discriminant ability, sensitivity, and specificity improve. The highest discriminant ability observed is the change in SRT, with a discriminant ability of 76% and an area under the ROC curve of 0.78. Combining the change in SRT, MTH, and MSP improves the area under the ROC curve to 0.79 but yields slightly lower discriminant ability of 75%. Again, no other single test or test combination improves these scores.
Impact of Covariates on ANAM Subtest Performance
Results are in Table 4 . Covariate analysis presented is limited to enrollment SRT alone as SRT + PRT was derived post hoc and provides only minimally improved results. Sample size was insufficient to allow analysis of covariates on change in SRT.
In controls, no covariate examined demonstrated a significant impact. Likewise, after the Bonferroni correction, median enrollment SRT did not vary significantly by any demographic factor, physical health parameter, mental health parameter, or deployment related factor in cases.
Impact of Using a Clinical Decision Tool
Results are shown in Table 5 . Performance of these tests' can be improved with the use of a clinical decision tool. Based on covariate analyses, a decision tool was created examining five symptoms: Pain, headache, blackouts, confusion, and mental health ,4 on a scale of 1 -5. All combinations of LOC/PTA and symptoms listed above were analyzed. The largest area under the ROC curve and discriminant ability were obtained by examining cases with either LOC/PTA or at least three symptoms. Using this tool, the discriminant ability for SRT at enrollment increased from 69% to 75% and change in SRT from baseline increased from 76% to 81%. Enrollment SRT + PRT improved from 71% to 76%. Although specificity was not altered by the clinical decision tool, remaining constant at above 80% for all, sensitivity increased using the tool, from 52% to 63% for SRT at enrollment, from 59% to 71% for SRT + PRT at enrollment, and from 71% to 81% for change in SRT from baseline. 
Concurrent Validity
Correlation of ANAM subtests with traditional neuropsychological testing was poor. No combination of traditional neuropsychological test results achieved a kappa .0.2 when compared with SRT in differentiating cases and controls. This does not imply that the ANAM lacks concurrent validity as SRT demonstrated significantly higher discriminant ability than any combination of traditional tests. No combination of traditional tests achieved discriminant ability greater than 62% for the entire case group or 70% using the clinical decision tool. Results show inferiority of the traditional tests in this setting, making their use as a gold standard for concurrent validity inappropriate. 
Discussion
Results clearly demonstrate that ANAM, and particularly SRT, is more effective than the traditional brief sports medicine neuropsychological battery in differentiating concussed from non-concussed participants in the combat environment when administered within 72 h of injury.
Equally important, limiting testing to SRT provides higher sensitivity and specificity than administering the entire ANAM. The current research replicates prior studies (Luethcke et al., 2011; McCrea, Prichep, Powell, Chabot, & Barr, 2010; Warden et al., 2001 ) supporting the sensitivity of SRT to concussion relative to other ANAM subtests, though findings have not been entirely consistent: In contrast to other reports, in a study of U.S. Military Academy athletes, Bleiberg and colleagues (2004) found that while SRT declined following concussion, SRT also declined in controls and they speculated the variance in their results with other studies may have reflected the overarching stressors occurring in military academy life. In any event, implications of the sensitivity of SRT to concussion for the development of a neuropsychological testing platform that is portable and readily adaptable to the field environment are of great importance for the Department of Defense. As ANAM is currently administered on a laptop and the SRT subtest is scored based on two administrations, one at the beginning and one at the end of the battery, these results need to be validated in an environment where only SRT or SRT and PRT are tested. However, if results are cross-validated, a shortened testing battery could be developed.
Another key finding of this study is that the establishment of baseline SRT is valuable, as changes in SRT are more sensitive and specific than one-time testing after a concussion. Because neurocognitive performance varies in healthy individuals by age, ethnic background, education, and developmental disorders such as learning disability (Collins, Grindel, & Lovell, 1999; Heaton, Miller, Taylor, & Grant, 1997) comparing post-concussion scores to an individualized baseline would be expected to result in greater diagnostic accuracy than comparison with a normative reference group. Evidence from sports medicine concussion research supports the value of baseline testing (Warden et al., 2001) and it is accepted as a component of comprehensive concussion management programs (Aubry et al., 2002; Barr et al., 2008) . The authors did not obtain in-theater baseline scores for concussed individuals, but one area of possible future exploration is whether changes in these neuropsychological test results versus in-theater baselines would be even more sensitive and specific.
The addition of a clinical decision tool incorporating subjective post-concussive symptoms improved sensitivity. Although a decrease in SRT of more than 1.5 points is 71% sensitive and 82% specific in differentiating concussions from controls, adding the clinical decision tool improves sensitivity to 81%, comparable with other neuropsychological tools described in sports medicine concussion literature (Barr et al., 2008; Broglio et al., 2007b; Schatz et al., 2006) and supporting evidence indicating algorithms combining neuropsychological results with the measurement of self-reported post-concussive symptoms increases diagnostic accuracy (Broglio et al., 2007a; Van Kampen et al., 2006) . The authors stress, though, that this tool was developed in post hoc analysis and is presented only as an example of how a clinical decision tool could enhance test performance, not to suggest that this tool be adopted.
Analysis of the impact of covariates on SRT in controls demonstrates the insensitivity of this test to non-concussive factors. No demographic, physical health, sleep, or service-related factor was significantly associated with SRT performance at enrollment at the p , .05 level.
In order to address the possibility of Type I error, the Bonferroni corrections were calculated and significance is presented with this adjustment. It should be noted that adjustment for multiple comparisons, while commonly used in neuropsychological studies, is not universally recommended and may increase the possibility of Type II error (Rothman, 1990) . Type II error may be a particular concern for studies of techniques designed to detect effects of concussion in soldiers being evaluated for return to hazardous duty. Cernich, Brennana, Barker, and Bleiberg (2007) provided an overview of technology centered concerns related to the equivalence of reaction time-based computerized neuropsychological tests (with specific reference to the ANAM battery) when the measures were utilized across different hardware configurations and operating systems. Cernich and colleagues (2007) indicate that there are several advantages of ANAM as a computerized neuropsychological test: The test has been verified as compatible with multiple operating systems (including the operating system employed in this study), timing accuracy has been verified through oscilloscope timing, the ANAM program detects screen settings and adjusts display size so that the display is full screen on all platforms, presentation of stimuli in ANAM coincides with the refresh rate of the display (promoting accurate timing of the display of test stimuli), and during test administration the ANAM disables all other programs in order to capture CPU resources. Our project made specific efforts to address other concerns raised by Cernich and colleagues (2007) . Although data for our study were collected in three locations, all used the same hardware (Dell D630), operating system (Windows XP), and a USB optical mouse as recommended by the test vendor. In addition, pre-deployment baseline ANAM assessments used in this project were collected on Dell D630 computers running Windows XP and using the recommended USB optical mouse as well. Because our ANAM testing was completed on freestanding computers without internet connectivity, sources of error related to assessments conducted in real time were eliminated.
Results from this study suggest that the ANAM, and particularly SRT, can detect changes in cognition following a concussion incurred in the combat environment that are both "statistically significant" and "clinically significant." The term statistical significance in clinical neuropsychology tends to be used in the context of testing the null hypothesis. Findings indicating that cases performed more poorly than controls on multiple ANAM subtests at the time of enrollment, and that there was deterioration in ANAM performance from pre-deployment baseline to enrollment in cases when compared with controls, support the statistical significance of our results (Table 2) . However, not all differences that are statistically significant can be considered practically clinically significant. For example, differences in function that are small in magnitude are not likely to be practically relevant. Likewise, differences in function common in a healthy population are also not likely clinically significant as they may merely be an indication of normal variation. One measure that has been proposed as a marker of practical clinical significance in clinical neuropsychology is effect size (Peterson, 2008) . Additional evaluation of our data set found that when individual change from baseline to enrollment was calculated for cases, effect sizes for most ANAM subtests (the exception was CDD) ranged from .29 to .46 with SRT having the largest effect size. These effect sizes are in the small to medium range but comparable to effect sizes seen in cognitive studies of other disorders including Attention-Deficit/Hyperactivity Disorder (ADHD), depression, and benzodiazepine withdrawal (Iverson, 2005) . Perhaps more importantly, SRT, particularly when used as a component of a clinical tool, provided encouraging discriminant ability results (Table 5) .
This study has several limitations. The first is that sample size, while sufficient to assess sensitivity and specificity of the tests under study, was insufficient to fully analyze the impact of cofactors potentially impacting neurocognitive performance. This study was underpowered to detect the impact of these cofactors on change in SRT from baseline.
Another limitation is that pre-deployment baseline scores were often not available, and there were no in-theater baseline scores. Although in the present study covariates did not significantly impact controls' SRT scores, prior work based on the comparison of neuropsychological testing done prior to deployment and roughly 3 months after deployment (Vasterling et al., 2006) has suggested that deployment itself could alter cognition, potentially confounding results (though it is possible that the Vasterling and colleagues (2006) data could have been affected by events occurring in the time interval between the end of deployment and post-deployment testing). In any case, in-theater baselines would potentially improve ANAM discriminant ability by limiting such a confound.
Lack of a detailed post-concussion symptom questionnaire administered at pre-deployment baseline and at enrollment is another limitation, as prior work from sports medicine has suggested combining structured symptom report with neuropsychological data increases discriminant ability (Broglio et al., 2007a; Van Kampen et al., 2006) .
It is possible, based on known natural history (Bleiberg et al., 2004; McCrea et al., 2009; Pellman, Lovell, Viano, Casson, & Tucker, 2004; Pellman et al., 2006) , that some cases had recovered from concussion by the time ANAM was administered. As such, results may underestimate initial ANAM sensitivity as testing was conducted no earlier than the day after concussion.
Neuropsychological testing is not a substitute for thorough examination by medical professionals or neuroimaging. Rather, testing is a tool to aid in clinical decision-making. Further validation of these findings is required. Particularly promising would be prospective validation of the use of SRT alone, either at enrollment or in comparison with baseline scores. The addition of other tests, such as PRT or a clinical decision tool, will also require prospective validation before general use can be recommended. Associations found in post hoc analysis must be viewed with healthy skepticism.
Findings from the present study have significant implications for military clinicians using the ANAM to assist in the evaluation and management of acute concussion in the combat zone, where the ANAM continues to be used by the Department of Defense as the primary computerized neuropsychological tool. When originally packaged for use in Iraq and Afghanistan, interpretation of the test relied on a "stoplight" system based on a large normative data set obtained from healthy soldiers tested in the USA; validation in a clinical population of soldiers suffering concussion was not yet available. In the stoplight system, scores are characterized as "average or above" (green), "below average" (yellow), or "clearly below average" (red) based on the standard score cutoffs in the healthy soldier normative group. Prior related work by our research team (Coldren, Russell, Kelly, Parish, & Dretsch, 2011) found that the ANAM stoplight method of interpretation was neither sensitive nor specific enough for clinical use: For soldiers tested in Iraq within 72 h of a concussion, the stoplight system yielded a sensitivity of only 52% and specificity of 75%. Data from the present study make available valuable preliminary clinical information regarding ANAM subtests most vulnerable to the effects of concussion within 72 h after injury and provide clinicians with an alternative approach to the stoplight for interpreting ANAM data. In addition, our findings provide initial support for the value of pre-deployment baseline evaluation in improving diagnostic accuracy (Tables 2, 3 , and 5) in acute concussion. Over time, the availability of baseline deployment scores has been growing, and data from our project should encourage clinicians evaluating patients early in the course of recovery from concussion to make efforts to obtain baseline scores for comparison.
We must also stress that the support for clinical use of the ANAM generated by this study is limited to clinical contexts involving the assessment of soldiers with acute (i.e., within 72 h of injury) concussion. Our findings do not provide support for the use of the ANAM as a population screening tool for concussion, as effects of concussion on objective measures of cognition typically resolve over a period of days to weeks (Bleiberg et al., 2004; Hugenholtz et al., 1988; McCrea et al., 2003) and many disorders other than concussion can impair performance on the ANAM and other computerized neuropsychological tests (Erlanger et al., 2002; Kane, Roebuck-Spencer, Short, Kabat, & Wilken, 2007) .
In summary, ANAM SRT within 72 h of a concussion, particularly if compared with baseline results, is a relatively sensitive and specific method to differentiate concussed from non-concussed individuals in the combat environment. It demonstrated superiority to the traditional neuropsychological tests and to the full ANAM-IV-TBI battery. The addition of PRT or a clinical decision tool may improve the discriminant ability of this testing. Findings provide initial support for the use of neuropsychological testing to assist in acute management of concussion on the battlefield and for the utility of pre-deployment baseline testing.
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